Lab of Cardiovascular Prevention Dipt of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.
Centro Cardiologico Monzino IRCCS, Milan, Italy.
Cardiovasc Diabetol. 2022 Oct 29;21(1):223. doi: 10.1186/s12933-022-01655-w.
BACKGROUND: Diabetes mellitus (DM) is associated with an increased mortality risk in patients hospitalized with acute myocardial infarction (AMI); however, no studies have investigated the impact of the duration of DM on in-hospital mortality. In this study, we evaluated in-hospital mortality in AMI patients according to DM status and its duration. METHODS: Using health administrative databases of Lombardy, DM patients≥50 years hospitalized with AMI from 2010 to 2019 were included in the analysis and were stratified according to the duration of DM: <5, 5-10, and > 10 years. The primary endpoint was mortality during AMI hospitalization and the secondary endpoint was 1-year mortality in comparison with No-DM patients. Logistic and Cox regressions analyses were used to estimate odds ratios (ORs, CI 95%) and hazard ratios (HRs, CI 95%) for the outcomes, according to DM status and duration and AMI type (STEMI and NSTEMI). RESULTS: Our study cohort comprised 29,566 and 109,247 DM and No-DM patients, respectively. Adjusted ORs and HRs showed a significantly higher risk of in-hospital mortality (OR 1.50, 95% CI 1.43-1.58) and 1-year mortality (HR 1.51, 95% CI 1.46-1.55) in DM patients in comparison with those without. These risks increased progressively with the duration of DM, with the highest risk observed in patients with DM duration ≥ 10 years (OR 1.59, 95% CI 1.50-1.69 for in-hospital mortality and HR 1.59, 95% CI 1.53-1.64 for 1-year mortality). These findings were similar in STEMI and in NSTEMI patients. CONCLUSIONS: Our study demonstrates that the duration of DM parallels mortality risk in patients hospitalized with AMI, highlighting that DM duration should be considered as an important early prognostic risk factor in patients with AMI.
背景:糖尿病(DM)与急性心肌梗死(AMI)住院患者的死亡率增加相关;然而,尚无研究调查 DM 持续时间对住院死亡率的影响。本研究评估了根据 DM 状态及其持续时间,AMI 患者的住院死亡率。
方法:使用伦巴第大区的健康管理数据库,纳入了 2010 年至 2019 年期间年龄≥50 岁因 AMI 住院的 DM 患者,并根据 DM 的持续时间进行分层:<5 年、5-10 年和>10 年。主要终点是 AMI 住院期间的死亡率,次要终点是与无 DM 患者相比的 1 年死亡率。根据 DM 状态和持续时间以及 AMI 类型(STEMI 和 NSTEMI),使用逻辑和 Cox 回归分析估计结局的比值比(OR,95%置信区间)和风险比(HR,95%置信区间)。
结果:本研究队列包括 29566 例 DM 患者和 109247 例无 DM 患者。调整后的 OR 和 HR 显示,DM 患者的住院死亡率(OR 1.50,95%CI 1.43-1.58)和 1 年死亡率(HR 1.51,95%CI 1.46-1.55)显著更高。这些风险随着 DM 的持续时间而逐渐增加,DM 持续时间≥10 年的患者风险最高(住院死亡率的 OR 1.59,95%CI 1.50-1.69;1 年死亡率的 HR 1.59,95%CI 1.53-1.64)。这些发现在 STEMI 和 NSTEMI 患者中相似。
结论:本研究表明,DM 的持续时间与 AMI 住院患者的死亡率风险相关,突出表明 DM 持续时间应被视为 AMI 患者的一个重要早期预后危险因素。
Cardiovasc Diabetol. 2022-10-29
Curr Vasc Pharmacol. 2020
Eur J Clin Pharmacol. 2025-9-9
Eur Heart J Digit Health. 2024-10-14
BMC Cardiovasc Disord. 2024-12-20
Cardiovasc Diabetol. 2024-10-30
Cardiovasc Toxicol. 2024-10
Pol Arch Intern Med. 2021-11-30